Drug Clustering via Vector Transformation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current computational methods for assessing drug efficacy and safety in drug discovery and clinical trials are inadequate, leading to high failure rates of drug candidates, and there is a need for improved methods to identify similar compounds and predict phenotypic relatedness.
Innovation Solution
A computer-implemented method that transforms vectors representing functional interactions between compounds and reagents into clusters, using normalization and clustering algorithms like k-means, to identify similar compounds and associate them with biomarkers, enabling more accurate prediction of drug efficacy and safety.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If current computational methods are used to assess drug efficacy and safety, then the assessment process is simple and fast, but the accuracy is insufficient leading to high failure rates
Solution Approach 1:
The patent transforms the assessment approach by changing parameters from simple IC50 values to transformed vectors that amplify certain functional interactions and saturate others. This transformation of the data parameters enables more accurate phenotypic relatedness prediction while maintaining computational feasibility
Solution Approach 2:
The patent moves from one-dimensional IC50 measurements to multi-dimensional vector representations of compound-reagent interactions. By adding dimensional complexity to the data structure (multiple reagents, transformed components), the system achieves higher assessment accuracy without proportionally increasing computational burden
2Measurement precision
If traditional clustering methods are used without vector transformation, then the computational process is simpler, but the identification of similar compounds is less accurate
Solution Approach 1:
The patent applies preliminary transformation to the compound-reagent interaction data before clustering. By pre-transforming the vectors to amplify important interactions and saturate less important ones, the system prepares the data in advance for more effective clustering, improving compound similarity identification accuracy
Solution Approach 2:
The transformation function modifies the parameters of compound-reagent interactions by amplifying certain functional interactions and saturating others. This parameter transformation enhances the discriminatory power of the data for clustering purposes, enabling more accurate identification of similar compounds
Data Source
AI summary
Grouping vectors describing functional interactions between compounds and reagents into clusters identifies groups of similar compounds, and may identify drug targets, pathways of action, deleterious toxicities, immune stimulation and evasion potential, or other information regarding interactions between compounds and reagents.